Immediate Impact

1 from Science/Nature 72 standout
Sub-graph 1 of 20

Citing Papers

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2022 Standout
Nasopharyngeal carcinoma: an evolving paradigm
2021 Standout
22 intermediate papers

Works of A Cheirsilpa being referenced

Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
Preliminary report of the asian‐oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
and 1 more

Author Peers

Author Last Decade Papers Cites
A Cheirsilpa 252 139 25 363 317 15 594
Hoda Al‐Booz 100 143 8 239 341 13 519
Avraham Eisbruch 180 268 61 253 328 13 658
Vilija N. Avizonis 229 175 44 292 347 11 692
Collin M.M. Lui 194 185 21 309 352 10 542
Y Decroix 189 88 41 234 131 19 659
Yupa Sumitsawan 303 168 25 348 433 17 644
O. Dalesio 305 323 34 234 32 25 597
Tommaso Bizzarro 144 96 72 365 44 28 669
Victy Y.W. Wong 170 226 7 305 335 18 546
Patrick M. Stafford 80 367 9 274 42 19 525

All Works

Loading papers...

Rankless by CCL
2026